The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 29, 2020

Filed:

Feb. 22, 2019
Applicant:

Bicycletx Limited, Cambridge, GB;

Inventors:

Liuhong Chen, Cambridge, GB;

Rachid Lani, Cambridge, GB;

Kevin McDonnell, Lexington, MA (US);

Gemma Elizabeth Mudd, Cambridge, GB;

Peter U. Park, Lincoln, MA (US);

Punit Upadhyaya, Lexington, MA (US);

Assignee:

BicycleTx Limited, Cambridge, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 4/00 (2006.01); A61K 38/00 (2006.01); C07K 7/08 (2006.01); C07K 2/00 (2006.01); A61K 47/64 (2017.01); A61K 47/66 (2017.01); A61P 35/00 (2006.01); C07K 7/64 (2006.01); C07K 17/02 (2006.01); A61K 47/60 (2017.01); C07K 17/14 (2006.01); A61K 47/59 (2017.01); C07K 14/705 (2006.01); A61K 47/54 (2017.01);
U.S. Cl.
CPC ...
C07K 7/08 (2013.01); A61K 47/59 (2017.08); A61K 47/60 (2017.08); A61K 47/64 (2017.08); A61K 47/66 (2017.08); A61P 35/00 (2018.01); C07K 2/00 (2013.01); C07K 7/64 (2013.01); C07K 14/70575 (2013.01); C07K 17/02 (2013.01); C07K 17/14 (2013.01); A61K 47/54 (2017.08); C07K 2319/00 (2013.01);
Abstract

The present invention relates to multimers of polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. The invention also describes the multimerization of polypeptides through various chemical linkers and hinges of various lengths and rigidity using different sites of attachments within polypeptides. In particular, the invention describes multimers of peptides which are high affinity binders and activators of CD137. The invention also includes drug conjugates comprising said peptides, conjugated to one or more effector and/or functional groups, to pharmaceutical compositions comprising said peptide ligands and drug conjugates and to the use of said peptide ligands and drug conjugates in preventing, suppressing or treating a disease or disorder mediated by CD137.


Find Patent Forward Citations

Loading…